Global transfusion practices in septic patients in the intensive care unit: insights from the InPUT-study sub-analysis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, pozorovací studie, multicentrická studie
Grantová podpora
GNT1189490
National Health and Medical Research Council
GNT1194811
National Health and Medical Research Council
PubMed
41122832
PubMed Central
PMC12704699
DOI
10.1111/trf.18445
Knihovny.cz E-zdroje
- MeSH
- jednotky intenzivní péče * MeSH
- krevní transfuze * metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- senioři MeSH
- sepse * terapie MeSH
- transfuze erytrocytů * MeSH
- transfuze trombocytů MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
BACKGROUND: Transfusion practices among intensive care unit (ICU) patients with sepsis vary widely. While restrictive hemoglobin thresholds for red blood cell (RBC) transfusion are well studied, the indications and thresholds for platelet and plasma transfusions remain uncertain. METHODS: We performed a sepsis-specific sub-analysis of the International Point Prevalence Study of Intensive Care Unit Transfusion Practices, a prospective, multicenter, observational study capturing all adult ICU admissions during four pre-scheduled weeks between March 2019 and October 2022. Patients admitted with sepsis or septic shock, or who developed sepsis during their ICU stay, were included. We recorded demographics, daily laboratory values, and transfusion triggers. Primary endpoints were the proportions of patients receiving RBCs, platelets, or plasma; secondary endpoints were indications, pre-transfusion thresholds, and blood loss. RESULTS: Among 3643 screened patients, 799 (22%) fulfilled sepsis criteria; within this subgroup, 317 (40%) received at least one blood component. RBCs were transfused in 269 patients (34%), primarily to address anemia or hemodynamic instability, at a mean pre-transfusion hemoglobin of 7.5 ± 1.4 g/dL, consistent with restrictive practice. Platelets were given to 78 patients (10%) for prophylaxis or active bleeding at a median count of 26 × 109 cells/L (interquartile range 16-51 × 109 cells/L). Plasma was administered to 108 patients (14%), half for bleeding control and half for non-bleeding indications. CONCLUSIONS: This largest international snapshot of septic ICU transfusion practices confirms adherence to restrictive RBC thresholds but reveals substantial variability in platelet and plasma use. These findings underscore the need for targeted trials to refine transfusion guidelines in sepsis.
Department of Anesthesia and Intensive Care Military Medical Academy Belgrade Belgrade Serbia
Department of Anesthesiology Aga Khan University Hospital Nairobi Kenya
Department of Anesthesiology Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Anesthesiology and Intensive Care IRCCS Humanitas Research Hospital Milan Italy
Department of Anesthesiology University Medical Center Groningen Groningen The Netherlands
Department of Cardiothoracic Surgery European Interbalkan Medical Center Thessaloniki Greece
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
Department of Critical Care Asgar Ali Hospital Dhaka Bangladesh
Department of Intensive Care Adults Erasmus MC University Medical Centers Rotterdam The Netherlands
Department of Intensive Care Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Intensive Care Pontificia Universidad Católica de Chile Santiago Chile
Department of Intensive Care Utrecht University Medical Centers Utrecht The Netherlands
Department of Pulmonary and Critical Care Columbia University New York New York USA
Department of Pulmonary and Critical Care New York University New York New York USA
Faculty of Medicine University of Tripoli Tripoli Libya
Intensive Care Service Hospital Universitario La Paz Madrid Spain
Médecine Intensive Réanimation CHU de Brest Université de Bretagne Occidentale Brest France
Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK
Unidad de Cuidados Intensivos Hospital Vicente Corral Moscoso Cuenca Ecuador
Zobrazit více v PubMed
Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, et al. Transfusion strategies in non‐bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. 2020;46(4):673–696. 10.1007/S00134-019-05884-8/TABLES/3 PubMed DOI PMC
Vincent JL, Jaschinski U, Wittebole X, Lefrant JY, Jakob SM, Almekhlafi GA, et al. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care. 2018;22(1):102. 10.1186/S13054-018-2018-9 PubMed DOI PMC
Zimmerman JL. Use of blood products in sepsis: an evidence‐based review. Crit Care Med. 2004;32(11 Suppl):S542–S547. 10.1097/01.CCM.0000145906.63859.1A PubMed DOI
Singer M, Deutschman CS, Seymour C, Seymour CW, Shankar‐Hari M, Annane D, et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA. 2016;315(8):801–810. 10.1001/JAMA.2016.0287 PubMed DOI PMC
Jansma G, de Lange F, Kingma WP, Vellinga NAR, Koopmans M, Kuiper MA, et al. ‘Sepsis‐related anemia’ is absent at hospital presentation; a retrospective cohort analysis. BMC Anesthesiol. 2015;15(1):55. 10.1186/S12871-015-0035-7 PubMed DOI PMC
Goyette RE, Key NS, Ely EW. Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med. 2004;25(6):645–659. 10.1055/S-2004-860979 PubMed DOI
Tinmouth A, Fergusson D, Yee IC, Hébert PC. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46(11):2014–2027. 10.1111/J.1537-2995.2006.01026.X PubMed DOI
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal‐directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. 10.1056/NEJMOA010307 PubMed DOI
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. 10.1097/CCM.0000000000005337 PubMed DOI
Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381–1391. 10.1056/NEJMOA1406617 PubMed DOI
Mazza BF, Freitas FGR, Barros MMO, Azevedo LCP, Machado FR. Blood transfusions in septic shock: is 7.0 g/dL really the appropriate threshold? Rev Bras Ter Intensiva. 2015;27(1):36–43. 10.5935/0103-507X.20150007 PubMed DOI PMC
Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, et al. Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta‐analysis. Ann Intensive Care. 2017;7(1):5. 10.1186/S13613-016-0226-5 PubMed DOI PMC
Bergamin FS, Almeida JP, Landoni G, Galas FRBG, Fukushima JT, Fominskiy E, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med. 2017;45(5):766–773. 10.1097/CCM.0000000000002283 PubMed DOI
Jonsson AB, Rygård SL, Hildebrandt T, Perner A, Møller MH, Russell L. Thrombocytopenia in intensive care unit patients: a scoping review. Acta Anaesthesiol Scand. 2021;65(1):2–14. 10.1111/AAS.13699 PubMed DOI
Dietrich M, Hölle T, Lalev LD, Loos M, Schmitt FCF, Fiedler‐Kalenka MO, et al. Plasma transfusion in septic shock—a secondary analysis of a retrospective single‐center cohort. J Clin Med. 2022;11(15):4367. 10.3390/JCM11154367/S1 PubMed DOI PMC
Ning S, Barty R, Liu Y, Heddle NM, Rochwerg B, Arnold DM. Platelet transfusion practices in the ICU: data from a large transfusion registry. Chest. 2016;150(3):516–523. 10.1016/J.CHEST.2016.04.004 PubMed DOI
He S, Fan C, Ma J, Tang C, Chen Y. Platelet transfusion in patients with sepsis and thrombocytopenia: a propensity score‐matched analysis using a large ICU database. Front Med. 2022;9:830177. 10.3389/FMED.2022.830177/FULL PubMed DOI PMC
van Baarle FLF, de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, et al. Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med. 2023;388(21):1956–1965. 10.1056/NEJMOA2214322 PubMed DOI
Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med. 2005;33(11):2667–2671. 10.1097/01.CCM.0000186745.53059.F0 PubMed DOI
Qin X, Zhang W, Zhu X, Hu X, Zhou W. Early fresh frozen plasma transfusion: is it associated with improved outcomes of patients with sepsis? Front Med. 2021;8:54859. 10.3389/FMED.2021.754859 PubMed DOI PMC
Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust. 2003;178(3):117–121. 10.5694/J.1326-5377.2003.TB05101.X PubMed DOI
De Bruin S, Scheeren TWL, Bakker J, van Bruggen R, Vlaar APJ. Transfusion practice in the non‐bleeding critically ill: an international online survey – the TRACE survey. Crit Care. 2019;23(1):309. 10.1186/S13054-019-2591-6 PubMed DOI PMC
Flint AWJ, Poole A, Raasveld SJ, Bailey M, Brady K, Chen PY, et al. Blood transfusion practices in intensive care: a prospective observational binational study. Crit Care Explor. 2025;7(3):e1197. 10.1097/CCE.0000000000001197 PubMed DOI PMC
Raasveld SJ, de Bruin S, Reuland MC, de Bruin S, van den Oord C, Schenk J, et al. Red blood cell transfusion in the intensive care unit. JAMA. 2023;330(19):1852–1861. 10.1001/JAMA.2023.20737 PubMed DOI PMC
Raasveld SJ, Vlaar APJ, Scheeren TWL, Bakker J, Aubron C. InPUT‐Study protocol. https://www.esicm.org/wp-content/uploads/2020/10/InPUT-study-C1-protocol-input-final-version-6.pdf. Accessed 4 Feb 2025
Nutritional anaemias . Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37. PMID: 4975372. PubMed
Ashworth I, Thielemans L, Chevassut T. Thrombocytopenia: the good, the bad and the ugly. Clin Med. 2022;22(3):214–217. 10.7861/CLINMED.2022-0146 PubMed DOI PMC
Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011;139(2):271–278. 10.1378/CHEST.10-2243 PubMed DOI
Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion. 2013;53(5):1050–1058. 10.1111/J.1537-2995.2012.03866.X PubMed DOI
Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients – a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care. 2007;35(6):874–880. 10.1177/0310057X0703500604 PubMed DOI
Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16(2):231–241. 10.1111/JTH.13911 PubMed DOI
Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation. J Intensive Care. 2016;4(1):23. 10.1186/S40560-016-0149-0 PubMed DOI PMC
Alcaina PS. Platelet transfusion: and update on challenges and outcomes. J Blood Med. 2020;11:19–26. 10.2147/JBM.S234374 PubMed DOI PMC
Salman SS, Fernández Pérez ER, Stubbs JR, Gajic O. The practice of platelet transfusion in the intensive care unit. J Intensive Care Med. 2007;22:105–110. 10.1177/0885066606297969 PubMed DOI
Warner MA, Chandran A, Frank RD, Kor DJ. Prophylactic platelet transfusions for critically ill patients with thrombocytopenia: a single‐institution propensity‐matched cohort study. Anesth Analg. 2019;128(2):288–295. 10.1213/ANE.0000000000002794 PubMed DOI PMC
Metcalf RA, Nahirniak S, Guyatt G, Bathla A, White SK, Al‐Riyami AZ, et al. Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines. JAMA. 2025;334(7):606–617. 10.1001/JAMA.2025.7529 PubMed DOI
Ugeskriftet.dk . The majority of patients in septic shock are transfused with fresh‐frozen plasma. Ugeskriftet.dk. https://ugeskriftet.dk/dmj/majority-patients-septic-shock-are-transfused-fresh-frozen-plasma. Accessed 16 Dec 2024
Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340(3):207–214. 10.1056/NEJM199901213400307 PubMed DOI
Saito S, Uchino S, Hayakawa M, Yamakawa K, Kudo D, Iizuka Y, et al. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care. 2019;50:23–30. 10.1016/J.JCRC.2018.11.009 PubMed DOI
Wang R, Liu R, Xu Z. Association between plasma transfusion and in‐hospital mortality in critically ill patients with sepsis‐induced coagulopathy. Shock. 2023;60(4):545–552. 10.1097/SHK.0000000000002209 PubMed DOI
Müller MC, Arbous MS, Spoelstra‐De Man AM, Vink R, Karakus A, Straat M, et al. Transfusion of fresh‐frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion. 2015;55(1):26–35. 10.1111/TRF.12750 PubMed DOI
Müller MCA, Straat M, Meijers JCM, Klinkspoor JH, de Jonge E, Arbous MS, et al. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy. J Thromb Haemost. 2015;13(6):989–997. 10.1111/JTH.12908 PubMed DOI
Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is fresh‐frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion. 2012;52(8):1673–1686. 10.1111/J.1537-2995.2011.03515.X PubMed DOI
Bryan AW, Staley EM, Kennell T, Feldman AZ, Williams LA, Pham HP. Plasma transfusion demystified: a review of the Key factors influencing the response to plasma transfusion. Lab Med. 2017;48(2):108–112. 10.1093/LABMED/LMX027 PubMed DOI PMC
Péju E, Llitjos JF, Charpentier J, François A, Marin N, Cariou A, et al. Impact of blood product transfusions on the risk of ICU‐acquired infections in septic shock. Crit Care Med. 2021;49(6):912–922. 10.1097/CCM.0000000000004887 PubMed DOI
Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52(Suppl 1):65S–79S. 10.1111/J.1537-2995.2012.03663.X PubMed DOI PMC